abs40.txt	addressing	social	determinants	of	health	(sdoh)	has	been	acknowledged	as	anessential	objective	for	the	promotion	both	population	and	healthequity		extant	literature	identified	seven	potential	areas	investment	toaddress	sdoh	investments	in	sexual	reproductive	family	planning	early	learning	child	care	education	universal	well	asinvestments	to	reduce	poverty	ensure	sustainable	economic	development	andcontrol	hazards	aim	this	paper	is	produce	a	'report	card'	oncanada's	success	reducing	socioeconomic	inequities	pertaining	tothese	policy	domains	assess	how	canadian	trends	compare	those	inthe	united	kingdom	(uk)	country	with	similar	welfare	system	summarising	evidence	from	published	studies	national	statistics	we	foundthat	canada's	best	successes	were	inequalities	earlylearning	health-specifically	improving	equityin	maternal	employment	infant	mortality	comparative	data	suggest	thatcanada's	outcomes	latter	like	uk	contrast	least	promising	equity	relation	hazardcontrol	(specifically	tobacco)	though	canada	ukobserved	smoking	slow	upward	trend	childpoverty	prevalence	distinct	uk's	small	but	steady	reduction	divergence	indicates	that	alternativeinvestment	types	levels	may	be	needed	achieve	outcomesto

abs240.txt	importance		preferential	delivery	of	docetaxel	to	tumors	by	prostate-specificmembrane	antigen	(psma)-targeted	nanoparticles	is	clinically	effective	and	theselective	reduction	psma-positive	circulating	tumor	cells	(ctcs)	aftertreatment	has	implications	for	patient	selection	disease	monitoring	objective	determine	the	safety	efficacy	bind-014	a	psma-directeddocetaxel-containing	nanoparticle	in	patients	with	metastaticcastration-resistant	prostate	cancer	(mcrpc)	design	setting	participants	multicenter	open-label	phase	2	clinicaltrial	42	chemotherapy-naive	progressing	mcrpc	after	treatmentwith	abiraterone	acetate	and/or	enzalutamide	was	conducted	from	june	24	2013	tojune	10	2016	intervention	treatment	at	dosage	60	mg/m2	givenintravenously	on	day	1	21-day	cycles	combination	prednisone	untildisease	progression	or	unacceptable	toxic	effects	occurred	main	outcomes	measures	primary	end	point	radiographicprogression-free	survival	according	working	group	2recommendations	response	evaluation	criteria	solid	version	secondary	points	included	prostate-specific	(psa)	(≥50%reduction	baseline)	changes	ctc	number	(from	≥5	<5	per	7	5ml	blood)	(cellsearch)	based	psma	expression	levelson	ctcs	were	also	evaluated	(epic	sciences)	results	among	(81%	white)	median	age	66	(range	50-85)years	doses	received	6	1-21)	psa	responsewas	observed	12	40	(30%	95%	ci	18%-45%)	measurable	diseaseresponse	19	(32%	[95%	15%-54%])	conversions	13	26(50%	32%-68%)	radiographic	progression-free	9	9(95%	1-12	6)	months	use	epic	sciences	non-epcam-based	ctcdetection	platform	detected	16	18	(89%)	11	(61%)had	above	analytical	threshold	level	(psmapositive)	baseline	0	4-72	4	ctcs/ml)	psma-positivectcs	preferentially	reduced	treatment-related	adverse	events	grade1	fatigue	(29	[69%])	nausea	(23	[55%])	neuropathy	(14[33%])	neutropenic	fever	(1	[2%])	conclusions	relevance	these	findings	suggest	that	isactive	well	tolerated	antitumoractivity	may	be	related	levels	which	suggests	thatpatients	who	are	likely	benefit	this	can	identified	beforetreatment	initiated	trial	registration	clinicaltrials	gov	identifier	nct01812746

abs340.txt	loss	of	the	short	arm	chromosome	3	(3p)	occurs	early	in	>95%	clear	cellrenal	cell	carcinoma	(ccrcc)		nearly	ubiquitous	3p	ccrcc	suggestshaploinsufficiency	for	tumor	suppressors	as	drivers	tumorigenesis	wepreviously	reported	methyltransferase	setd2	which	trimethylates	h3	histones	onlysine	36	(h3k36me3)	and	is	located	deletion	to	also	trimethylatemicrotubules	on	lysine	40	(αtubk40me3)	during	mitosis	with	αtubk40me3	requiredfor	genomic	stability	we	now	show	that	monoallelic	setd2-deficient	cellsretaining	h3k36me3	but	not	exhibit	a	dramatic	increase	mitoticdefects	micronuclei	count	increased	viability	compared	biallelicloss	setd2-inactivated	human	kidney	cells	rescue	pathogenic	setd2mutant	deficient	microtubule	histone	(h3k36me3)methylation	replicated	this	phenotype	instability	(micronuclei)	wasalso	hallmark	patient-derived	from	these	data	thesetd2	suppressor	displays	haploinsufficiency	disproportionatelyimpacting	methylation	serves	an	driver	genomicinstability	significance	single	allele	chromatin	modifier	plays	arole	promoting	oncogenesis	underscoring	growing	relevance	tumorsuppressor	cancer	res	78(12)	3135-46	©2018	aacr

abs140.txt	human	endogenous	retroviruses	(hervs)	are	remnants	of	exogenous	thathave	integrated	into	the	genome	throughout	evolution		we	developed	acomputational	workflow	hervquant	which	identified	more	than	3	000transcriptionally	active	hervs	within	cancer	atlas	(tcga)	pan-cancerrna-seq	database	herv	expression	was	associated	with	clinical	prognosis	inseveral	tumor	types	most	significantly	clear	cell	renal	carcinoma	(ccrcc)	explored	two	mechanisms	by	may	influence	tumorimmune	microenvironment	in	ccrcc	(i)	rig-i-like	signaling	and	(ii)	retroviralantigen	activation	adaptive	immunity	demonstrated	ability	hervsignatures	these	immune	to	predict	patient	survival	inccrcc	independent	staging	molecular	subtyping	identifiedpotential	tumor-specific	epitopes	evidence	translational	activitythrough	use	a	ribosome	profiling	(ribo-seq)	dataset	validated	theirability	bind	hla	vitro	presence	mhctetramer-positive	t	cells	against	predicted	sequences	identifiedthrough	this	screening	approach	were	highly	expressed	ccrcctumors	responsive	treatment	programmed	death	receptor	1	(pd-1)inhibition	provides	insights	role	as	well	that	could	serve	asa	biomarker	for	response	immunotherapy

